Standard Biotools Inc (LAB)
Company Info
| ISIN | US34385P1084 |
|---|---|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Highlights
| Market Cap | $909.27M |
|---|---|
| EPS | -$0.94 |
| Revenue (TTM) | $126.76M |
| Gross Profit (TTM) | -$1.45M |
| EBITDA (TTM) | -$80.13M |
| Year Range | $1.57 - $3.16 |
| Target Price | $3.63 |
| Short % | 3.16% |
| Short Ratio | 3.53 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Standard Biotools Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Standard Biotools Inc had a return of 12.22% year-to-date (YTD) and 40.11% in the last 12 months. Over the past 10 years, Standard Biotools Inc had an annualized return of -21.31%, while the S&P 500 had an annualized return of 10.79%, indicating that Standard Biotools Inc did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 12.22% | 9.47% |
| 1 month | -11.11% | 1.91% |
| 6 months | 13.24% | 18.36% |
| 1 year | 40.11% | 26.61% |
| 5 years (annualized) | -27.20% | 12.90% |
| 10 years (annualized) | -21.31% | 10.79% |
Monthly Returns
The table below presents the monthly returns of LAB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2.71% | -0.88% | 20.44% | -8.49% | 12.22% | ||||||||
| 2023 | 70.94% | -9.00% | 7.14% | -12.82% | 38.24% | -17.87% | 26.94% | 22.45% | -3.33% | -31.38% | 29.65% | -14.34% | 88.89% |
| 2022 | -16.58% | 12.54% | -2.45% | -26.18% | -28.68% | -15.34% | -9.38% | -2.76% | -21.99% | 7.27% | 17.80% | -15.83% | -70.15% |
| 2021 | 8.00% | -29.01% | -1.74% | 10.84% | 15.77% | 6.21% | 20.29% | -2.70% | -8.60% | -21.85% | -10.49% | -14.97% | -34.67% |
| 2020 | 10.34% | -13.54% | -23.49% | -11.81% | 94.64% | -8.03% | 75.56% | 11.51% | -5.35% | -22.75% | 9.06% | -4.15% | 72.41% |
| 2019 | 0.35% | 27.86% | 20.16% | 3.39% | -4.73% | -5.88% | -4.63% | -52.51% | -17.03% | 6.26% | -48.78% | 38.10% | -59.63% |
| 2018 | 4.07% | 10.44% | -13.74% | 1.03% | -5.59% | 7.00% | 7.38% | 23.75% | -5.43% | -3.87% | 13.89% | 5.12% | 46.35% |
| 2017 | -13.05% | 3.63% | -13.26% | -13.18% | -8.30% | -10.82% | -6.93% | 21.54% | 10.28% | 15.08% | 2.59% | -1.01% | -19.09% |
| 2016 | -37.93% | -1.19% | 21.72% | 18.71% | 2.71% | -8.23% | 16.83% | -13.65% | -12.07% | -42.20% | 38.88% | 13.22% | -32.65% |
| 2015 | 14.23% | 14.72% | -4.75% | -11.02% | -36.89% | 2.37% | -17.23% | -39.14% | -33.47% | 33.29% | 5.18% | -4.93% | -67.95% |
| 2014 | 17.87% | 3.83% | -5.93% | -14.77% | -26.14% | 5.98% | -2.62% | -4.92% | -9.99% | 18.37% | 6.31% | 9.41% | -11.89% |
| 2013 | 15.30% | 4.48% | 7.37% | -9.02% | 1.19% | 2.46% | 1.72% | 15.20% | 7.23% | 43.57% | 0.89% | 20.45% | 167.51% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of LAB is 65, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
LAB (Standard Biotools Inc)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Standard Biotools Inc (LAB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Standard Biotools Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Standard Biotools Inc was 98.10%, occurring on Nov 9, 2022. The portfolio has not yet recovered.
The current Standard Biotools Inc drawdown is 94.93%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.1% | Mar 6, 2014 | 2188 | Nov 9, 2022 | — | — | — |
| -40.15% | Jul 25, 2011 | 21 | Aug 22, 2011 | 493 | Aug 8, 2013 | 514 |
| -17.4% | May 2, 2011 | 27 | Jun 8, 2011 | 14 | Jun 28, 2011 | 41 |
| -12.9% | Mar 18, 2011 | 10 | Mar 31, 2011 | 20 | Apr 29, 2011 | 30 |
| -8.67% | Feb 18, 2011 | 11 | Mar 7, 2011 | 5 | Mar 14, 2011 | 16 |
Volatility
Volatility Chart
The current Standard Biotools Inc volatility is 14.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |